XML 21 R8.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Cash Equivalents and Investments | 9 Months Ended
--- | ---
Sep. 30, 2018
Investments Debt And Equity Securities [Abstract] |
Cash Equivalents and Investments | 3.Cash Equivalents and Investments At September 30, 2018 and December 31, 2017, the balance in the Company’s accumulated other comprehensive income was comprised solely of activity related to the Company’s available‑for‑sale securities. There were no realized gains or losses recognized on the sale or maturity of available‑for‑sale securities during the three and nine months ended September 30, 2018 and 2017 and as a result, the Company did not reclassify any amounts out of accumulated other comprehensive income for the same periods. All of the Company’s available-for-sale securities are subject to a periodic impairment review. The Company considers an investment security to be impaired when its fair value is less than its carrying cost, in which case the Company would further review the investment to determine whether it is other-than-temporarily impaired. When the Company evaluates an investment for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer and any changes thereto, intent to sell, and whether it is more likely than not the Company will be required to sell the investment before the recovery of its cost basis. If an investment is other-than-temporarily impaired, the Company writes it down through earnings to its impaired value and establishes that as a new cost basis for the investment. The Company did not identify any of its available-for-sale securities as other-than-temporarily impaired in any of the periods presented. As of September 30, 2018, no investment was in a continuous unrealized loss position for more than one year, the unrealized losses were not due to change in credit risk, and the Company believes that it is more likely than not the investments will be held until maturity. The following table summarizes the available‑for‑sale securities (in thousands):
|  | Amortized Cost |  |  | Unrealized Gains |  |  | Unrealized Losses |  |  | Fair Value |
September 30, 2018 (unaudited) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Money market funds |  | $ | 9,850 |  |  | $ | — |  |  | $ | — |  |  | $ | 9,850 |
Corporate notes |  |  | 31,749 |  |  |  | — |  |  |  | (55 | ) |  |  | 31,694 |
Commercial paper |  |  | 83,744 |  |  |  | — |  |  |  | — |  |  |  | 83,744 |
Asset backed securities |  |  | 12,226 |  |  |  | — |  |  |  | (28 | ) |  |  | 12,198 |
Government notes |  |  | 12,448 |  |  |  | — |  |  |  | (18 | ) |  |  | 12,430 |
Total |  | $ | 150,017 |  |  | $ | — |  |  | $ | (101 | ) |  | $ | 149,916 |
|  | Amortized Cost |  |  | Unrealized Gains |  |  | Unrealized Losses |  |  | Fair Value |
December 31, 2017: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Money market funds |  | $ | 8,685 |  |  | $ | — |  |  | $ | — |  |  | $ | 8,685 |
Corporate notes |  |  | 46,133 |  |  |  | — |  |  |  | (35 | ) |  |  | 46,098 |
Government notes |  |  | 6,191 |  |  |  | — |  |  |  | (16 | ) |  |  | 6,175 |
Total |  | $ | 61,009 |  |  | $ | — |  |  | $ | (51 | ) |  | $ | 60,958 |

X
- Definition The entire disclosure of the components of cash, cash equivalents, and short-term investments. Short-term investments may include current marketable securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 305 -URI http://asc.fasb.org/topic&trid=2122426 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -URI http://asc.fasb.org/topic&trid=2196928 + Details
Name: | us-gaap_CashCashEquivalentsAndShortTermInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration